Investment Summary |
|
|---|---|
| Date | 2022-04-12 |
| Target | Sonosemi |
| Sector | Medical Products |
| Investor(s) | Eight Roads |
| Deal Type | Venture |
SEARCH BY
| Category | Private Equity Firm |
|---|---|
| Founded | 1969 |
| PE ASSETS | 11.0B USD |
| Size | Mega |
| Type | Sector Focused |
Eight Roads is a private investment firm focused on a variety of investment opportunities across the US, Europe, and Asia. The Firm is divided into several investment strategies including venture, principal investing, and real estate. Within the principal investments group, Eight Roads backs established growth businesses with long-term capital. Eight Roads does not have any sector preferences, but has experience in fintech, business services, and healthcare. Eight Roads is based in London.
| DEAL STATS | # |
|---|---|
| Overall | 281 of 293 |
| Sector: Medical Products M&A | 15 of 15 |
| Type: Venture M&A Deals | 255 of 266 |
| Country: China M&A | 62 of 66 |
| Year: 2022 M&A | 12 of 23 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2022-04-12 |
Noogata
Tel Aviv, Israel Noogata provides no-code artificial intelligence (AI) for enterprises. Its AI platform is built for business users who need to turn their data into actionable insights quickly and easily to drive opportunities, growth, and profit. Noogata delivers the benefits of best-in-class AI for maximum business impact without the complexity and costs of having to develop or maintain your own models. Noogata was founded in 2019 and is based in Tel Aviv, Israel. |
Buy | - |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2022-04-19 |
Checkmate Pharmaceuticals
Cambridge, Massachusetts, United States Checkmate Pharmaceuticals is a clinical-stage biopharmaceutical company focused on the activation of innate immunity to treat cancer. Checkmate Pharmaceuticals was formed in 2015 and is based in Cambridge, Massachusetts. |
Sell | $250M |
